International Stem Cell Corporation
ISCO
$0.11
-$0.001-0.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 102.40% | 4.58% | -75.81% | -529.41% | -2,091.30% |
| Total Depreciation and Amortization | 12.50% | 12.77% | 4.17% | -3.92% | -7.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.19% | -19.02% | 24.06% | 20.56% | 51.11% |
| Change in Net Operating Assets | -206.35% | 376.27% | -56.11% | -1,389.47% | 269.89% |
| Cash from Operations | -145.96% | 314.52% | -95.31% | -189.35% | 103.80% |
| Capital Expenditure | -- | -164.29% | -135.29% | 46.67% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.33% | -- | -- | -- | 0.00% |
| Cash from Investing | 0.00% | -185.71% | -133.33% | 40.00% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -148.73% | -64.58% | -121.87% | -200.50% | 107.89% |